271 related articles for article (PubMed ID: 23909996)
1. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
[TBL] [Abstract][Full Text] [Related]
2. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
[TBL] [Abstract][Full Text] [Related]
3. Levels of evidence in canine oncology trials--a case in point.
Vail DM
Vet Comp Oncol; 2013 Sep; 11(3):167-8. PubMed ID: 23909995
[No Abstract] [Full Text] [Related]
4. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
5. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
[TBL] [Abstract][Full Text] [Related]
6. Use of the melanoma vaccine in 38 dogs: The South African experience.
McLean JL; Lobetti RG
J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
Treggiari E; Grant JP; North SM
J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
[TBL] [Abstract][Full Text] [Related]
11. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
[TBL] [Abstract][Full Text] [Related]
12. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
[TBL] [Abstract][Full Text] [Related]
13. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional retrospective study of canine foot pad malignant melanomas: 20 cases.
Jeon MD; Leeper HJ; Cook MR; McMillan SK; Bennett T; Murray CA; Tripp CD; Curran KM
Vet Comp Oncol; 2022 Dec; 20(4):854-861. PubMed ID: 35771690
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006-2012).
Kawabe M; Mori T; Ito Y; Murakami M; Sakai H; Yanai T; Maruo K
J Am Vet Med Assoc; 2015 Nov; 247(10):1146-53. PubMed ID: 26517618
[TBL] [Abstract][Full Text] [Related]
16. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
[TBL] [Abstract][Full Text] [Related]
17. USDA licenses DNA vaccine for treatment of melanoma in dogs.
J Am Vet Med Assoc; 2010 Mar; 236(5):495. PubMed ID: 20187810
[No Abstract] [Full Text] [Related]
18. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome.
Tellado MN; Maglietti FH; Michinski SD; Marshall GR; Signori E
Radiol Oncol; 2020 Mar; 54(1):68-78. PubMed ID: 32187017
[TBL] [Abstract][Full Text] [Related]
19. Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs.
Manley CA; Leibman NF; Wolchok JD; Rivière IC; Bartido S; Craft DM; Bergman PJ
J Vet Intern Med; 2011; 25(1):94-9. PubMed ID: 21143299
[TBL] [Abstract][Full Text] [Related]
20. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
